Skip to main content
. 2021 Aug 30;11:17324. doi: 10.1038/s41598-021-96467-5

Figure 2.

Figure 2

FAERS/AERS cohorts based on indications and treatments in efficacy trials for all ICIs. The two groups on each sub-cohort indicate the treatment vs control used in the efficacy trials. NSCLC non-small cell lung cancer, SCLC small cell lung cancer, RCC renal cell carcinoma, MCC Merkel cell carcinoma, CSCC cutaneous squamous cell carcinoma.